Chinese drug regulators approved APT Medical (SHA:688617) subsidiary Hunan APT Medical Equipment's medical device registration for polyvinyl alcohol embolization microspheres, according to a Wednesday filing with the Shanghai bourse.
The product is used for embolization therapy, or oxygen starvation, of malignant tumors, in solid organs with abundant blood vessels, the filing said.
Shares fell nearly 1% during afternoon trading on Wednesday.